Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

9,958 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Selenoprotein P as a diabetes-associated hepatokine that impairs angiogenesis by inducing VEGF resistance in vascular endothelial cells.
Ishikura K, Misu H, Kumazaki M, Takayama H, Matsuzawa-Nagata N, Tajima N, Chikamoto K, Lan F, Ando H, Ota T, Sakurai M, Takeshita Y, Kato K, Fujimura A, Miyamoto K, Saito Y, Kameo S, Okamoto Y, Takuwa Y, Takahashi K, Kidoya H, Takakura N, Kaneko S, Takamura T. Ishikura K, et al. Among authors: kato k. Diabetologia. 2014 Sep;57(9):1968-76. doi: 10.1007/s00125-014-3306-9. Epub 2014 Jul 3. Diabetologia. 2014. PMID: 24989996
Beneficial effect of branched-chain amino acid supplementation on glycemic control in chronic hepatitis C patients with insulin resistance: implications for type 2 diabetes.
Takeshita Y, Takamura T, Kita Y, Ando H, Ueda T, Kato K, Misu H, Sunagozaka H, Sakai Y, Yamashita T, Mizukoshi E, Honda M, Kaneko S. Takeshita Y, et al. Among authors: kato k. Metabolism. 2012 Oct;61(10):1388-94. doi: 10.1016/j.metabol.2012.03.011. Epub 2012 Apr 20. Metabolism. 2012. PMID: 22520843 Free article. Clinical Trial.
Pharmacokinetics and pharmacodynamics of insulin aspart in patients with type 2 diabetes: assessment using a meal tolerance test under clinical conditions.
Ando H, Kurita S, Shimizu A, Kato K, Ishikura K, Taji K, Uno M, Takeshita Y, Misu H, Fujimura A, Kaneko S, Takamura T. Ando H, et al. Among authors: kato k. Clin Exp Pharmacol Physiol. 2012 Jun;39(6):528-34. doi: 10.1111/j.1440-1681.2012.05708.x. Clin Exp Pharmacol Physiol. 2012. PMID: 22642657 Clinical Trial.
Metformin prevents and reverses inflammation in a non-diabetic mouse model of nonalcoholic steatohepatitis.
Kita Y, Takamura T, Misu H, Ota T, Kurita S, Takeshita Y, Uno M, Matsuzawa-Nagata N, Kato K, Ando H, Fujimura A, Hayashi K, Kimura T, Ni Y, Otoda T, Miyamoto K, Zen Y, Nakanuma Y, Kaneko S. Kita Y, et al. Among authors: kato k. PLoS One. 2012;7(9):e43056. doi: 10.1371/journal.pone.0043056. Epub 2012 Sep 18. PLoS One. 2012. PMID: 23028442 Free PMC article.
Proteasome dysfunction mediates obesity-induced endoplasmic reticulum stress and insulin resistance in the liver.
Otoda T, Takamura T, Misu H, Ota T, Murata S, Hayashi H, Takayama H, Kikuchi A, Kanamori T, Shima KR, Lan F, Takeda T, Kurita S, Ishikura K, Kita Y, Iwayama K, Kato K, Uno M, Takeshita Y, Yamamoto M, Tokuyama K, Iseki S, Tanaka K, Kaneko S. Otoda T, et al. Among authors: kato k. Diabetes. 2013 Mar;62(3):811-24. doi: 10.2337/db11-1652. Epub 2012 Dec 3. Diabetes. 2013. PMID: 23209186 Free PMC article.
Ursodeoxycholic acid potentiates dipeptidyl peptidase-4 inhibitor sitagliptin by enhancing glucagon-like peptide-1 secretion in patients with type 2 diabetes and chronic liver disease: a pilot randomized controlled and add-on study.
Shima KR, Ota T, Kato KI, Takeshita Y, Misu H, Kaneko S, Takamura T. Shima KR, et al. BMJ Open Diabetes Res Care. 2018 Mar 17;6(1):e000469. doi: 10.1136/bmjdrc-2017-000469. eCollection 2018. BMJ Open Diabetes Res Care. 2018. PMID: 29607050 Free PMC article.
9,958 results